Three RNAi, miRNA Firms Record Strong Gains in Stock Value Since the End of 2008
April 30, 2009
Three RNAi, miRNA Firms Record Strong Gains in Stock Value Since the End of 2008
By Doug Macron
The companies — Rosetta Genomics, MDRNA, and Tekmira Pharmaceuticals — have all seen their shares more than double since Dec. 31, significantly outperforming the Nasdaq Biotechnology Index.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.